Delaying the Onset of Nearsightedness Until Treatment Study

NCT06029530 · clinicaltrials.gov ↗
PHASE1
Phase
WITHDRAWN
Status
OTHER
Sponsor class

Stopped sIRB determined feasibility study could not be done because of no benefits of the treatment drops in short time violated FDA requirements

Conditions

Interventions

Sponsor

Ohio State University

Collaborators